Liquiritigenin

CAS No. 578-86-9

Liquiritigenin( Liquiritigenin | MF101 | MF 101 | MF-101 | Menerba )

Catalog No. M15122 CAS No. 578-86-9

Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 43 In Stock
10MG 61 In Stock
25MG 138 In Stock
50MG 221 In Stock
100MG 282 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Liquiritigenin
  • Note
    Research use only, not for human use.
  • Brief Description
    Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes
  • Description
    Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Liquiritigenin | MF101 | MF 101 | MF-101 | Menerba
  • Pathway
    Endocrinology/Hormones
  • Target
    Estrogen Receptor/ERR
  • Recptor
    ERβ
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    578-86-9
  • Formula Weight
    256.25
  • Molecular Formula
    C15H12O4
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    O=C1C[C@@H](C2=CC=C(O)C=C2)OC3=CC(O)=CC=C13
  • Chemical Name
    (S)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kim, YW. Gastrointestinal and Liver Physiology. 296 (2): G372–81.
molnova catalog
related products
  • Y134

    Y134 is an estrogen receptor inhibitor that is selective and orally active, exhibiting strong antagonist activity against ERα and Erβ with Ki of 0.09 nM and 11.31 nM, respectively.

  • Estrogen receptor mo...

    Estrogen receptor modulator 1 causes regression of Tamoxifen-resistant, hormone-independent xenograft tumors. Estrogen receptor modulator 1 is an orally active and selective estrogen receptor modulator (SERM) (pIC50: 0.46).

  • Fulvestrant

    Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast Y in post-menopausal women with disease progression following anti-estrogen therapy.